Metraipolis › archive › dc_4872134b442d
Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis — Europe PMC PMID:42292353
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42292353
- DOI
- 10.3389/fimmu.2026.1851837
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T04:07:40.734Z
- SHA-256 of the archived text
16ab12fd2f294ef20d0b4d95bc2da7a049015a348875b366bad963d3e4c4d0be- Stable URL of this page
https://metraipolis.com/documento/dc_4872134b442d
How to cite
Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis — Europe PMC PMID:42292353 — Europe PMC (en), https://europepmc.org/article/MED/42292353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4872134b442d (Metraipolis archive dc_4872134b442d, sha256 16ab12fd2f294ef20d0b4d95bc2da7a049015a348875b366bad963d3e4c4d0be)
BibTeX
@misc{dc4872134b442d,
title = {Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis — Europe PMC PMID:42292353},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42292353},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4872134b442d; sha256 16ab12fd2f294ef20d0b4d95bc2da7a049015a348875b366bad963d3e4c4d0be},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292353. Agents can read the archived copy with the MCP tool read_document.